Randomized, open-label, Phase 3 study of the effect of venglustat on left ventricular mass index in Fabry disease

Protocol Name: Randomized, open-label, Phase 3 study of the effect of venglustat on left ventricular mass index in Fabry disease

Sponsor: Sanofi-Aventis

Indication: Fabry Disease

Principal Investigator: Ankit Mehta, MD

Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204